PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention. [electronic resource]
Producer: 20090629Description: 721-7 p. digitalISSN:- 0253-6269
- Adipogenesis -- drug effects
- Administration, Oral
- Animals
- Blood Glucose -- drug effects
- Blood Volume -- drug effects
- Cells, Cultured
- Diabetes Mellitus, Type 2 -- drug therapy
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Partial Agonism
- Genes, Reporter
- Humans
- Hypoglycemic Agents -- administration & dosage
- Isoxazoles -- administration & dosage
- Male
- Mesenchymal Stem Cells -- drug effects
- Mice
- Mice, Inbred ICR
- PPAR gamma -- agonists
- Propionates -- administration & dosage
- Rosiglitazone
- Thiazolidinediones -- pharmacology
- Thiophenes -- administration & dosage
- Transfection
- Water-Electrolyte Balance -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.